MiMedx Group CEO Sells $1,242,000 in Stock (MDXG)
MiMedx Group (NASDAQ:MDXG) CEO Parker H. Petit unloaded 150,000 shares of the stock in a transaction dated Friday, January 17th. The stock was sold at an average price of $8.28, for a total transaction of $1,242,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
MiMedx Group (NASDAQ:MDXG) traded up 2.05% during mid-day trading on Tuesday, hitting $8.48. 560,605 shares of the company’s stock traded hands. MiMedx Group has a 1-year low of $1.81 and a 1-year high of $8.80. The stock has a 50-day moving average of $7.78 and a 200-day moving average of $6.00. The company’s market cap is $829.8 million.
MDXG has been the subject of a number of recent research reports. Analysts at Northland Capital Partners downgraded shares of MiMedx Group from an “outperform” rating to a “market perform” rating in a research note to investors on Monday, January 6th. They now have a $6.00 price target on the stock. Separately, analysts at Northland Securities downgraded shares of MiMedx Group from an “outperform” rating to a “market perform” rating in a research note to investors on Monday, January 6th. They noted that the move was a valuation call. Finally, analysts at Canaccord Genuity raised their price target on shares of MiMedx Group to $12.00 in a research note to investors on Friday, December 20th.
MiMedx Group, Inc is a development-stage company. The Company is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products and allografts processed from human amniotic membrane.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.